Skip to main content

Latest Market News — Page 162

Page 162 · 30 stories scored 7+ · newest 7:37 AM ET · How scores work

Mon, Aug 1030 stories
7CBZCBIZ, Inc.Investor Probe Targets CBIZ's $5B Sale as Q2 Earnings PlungeLegal & risk · Wiseek News▼ Negative8OUTOUTFRONT Media Inc.OUTFRONT Media Q2 Revenue Jumps 14% on World Cup and Transit StrengthEarnings & guidance · Wiseek News▲ PositivePro7BRBroadridge Financial Solutions, Inc.Broadridge Partners with Payward for Web3 Voting on Tokenized EquitiesProduct & regulatory · Wiseek News▲ Positive7CRLCharles River Laboratories International, Inc.Analyst Hikes and 11% Surge Cap Charles River's Strong Q2 WeekEarnings & guidance · Wiseek News▲ Positive8GNKGENCO SHIPPING & TRADING LTDGenco Posts Record Q2, Hikes Dividend, and Adds Capesize VesselEarnings & guidance · Wiseek News▲ PositivePro7DHXDHI Group, Inc.DHI Group Q2 Mixed: ClearanceJobs Surges 14%, Dice Slides 14%Earnings & guidance · Wiseek News● Neutral7AMWLAmerican Well CorpAmwell Raises 2026 Revenue Guidance to $200M–$205M, Narrows EBITDA LossEarnings & guidance · Wiseek News▲ Positive7TBLATaboola.com Ltd.Law Firm Opens Securities Probe Into Taboola's 2026 OutlookLegal & risk · Wiseek News▼ Negative8MNKDMannKind CorporationMannKind Q2 Revenue Jumps 43% to $109M, Narrows Loss; Nintedanib DPI Phase 2 PlannedEarnings & guidance · Wiseek News▲ PositivePro7BGSFBGSF, Inc.BGSF Q2 Loss Narrows to $0.8M, Unveils AI Recruiting and PropTech PushEarnings & guidance · Wiseek News▲ Positive8PCVXVaxcyte, Inc.Vaxcyte's VAX-31 Phase 3 Trials Fully Enrolled, Topline Data Set for Q4 2026Product & regulatory · Wiseek News▲ PositivePro8VIRVir Biotechnology, Inc.Vir Biotech Posts $80.1M Q2 Profit, 88% HDV Clearance in Key TrialEarnings & guidance · Wiseek News▲ PositivePro7BENFranklin Resources, Inc.$750M Senior Notes Priced as AUM Hits $1.80T, Leadership ReshuffledFinancing · Wiseek News● Neutral7LNTHLantheus Holdings, Inc.Lantheus Buyout Nears Close as FDA Decision on Alzheimer's Tracer LoomsM&A & partnerships · Wiseek News▲ Positive7ZNTLZentalis Pharmaceuticals, Inc.Zentalis Q2 Loss Wider Than Expected, But Cash Runway Extends to Late 2027Earnings & guidance · Wiseek News● Neutral7SVCService Properties TrustQ2 Revenue Drops 16% as Impairments Drive $224M Loss; Guidance ReaffirmedEarnings & guidance · Wiseek News▼ Negative8RCATRed Cat Holdings, Inc.Red Cat Q2 Revenue Surges 527% to $20.2M, Reiterates $150–180M FY GuidanceEarnings & guidance · Wiseek News▲ PositivePro7FRSHFreshworks Inc.Freshworks Guides Q3 Revenue to $245M, Raises Full-Year OutlookEarnings & guidance · Wiseek News▲ Positive7PRDOPERDOCEO EDUCATION CorpPerdoceo Q2 Revenue Hits $213.4M, Launches $100M Buyback and Hikes DividendEarnings & guidance · Wiseek News▲ Positive8SAFTSafety Insurance Group IncLaw Firm Probes Safety Insurance's $105/Share Sale to MapfreLegal & risk · Wiseek News▼ NegativePro7CTMXCytomX Therapeutics, Inc.Varseta-M Phase 1 Enrollment Complete, Data by Year-End; Q2 Revenue Plunged 92%Product & regulatory · Wiseek News▲ Positive8NTGRNETGEAR, INC.NETGEAR Posts $7.25M Q2 Loss, Guides Q3 Revenue to $165–$175MEarnings & guidance · Wiseek News▼ NegativePro7PDFSPDF SOLUTIONS INCPDF Solutions Q2 Revenue Jumps 19% to $61.5M, Backlog Hits $270.7MEarnings & guidance · Wiseek News▲ Positive7QBTSD-Wave Quantum Inc.D-Wave H1 Revenue Plunges 67% to $5.9M, Net Loss Hits $66.4MEarnings & guidance · Wiseek News▼ Negative7PEPGPepGen Inc.PepGen's DM1 Drug Cleared for 12.5 mg/kg Dose; Cash Runway Extended to Q4 2027Product & regulatory · Wiseek News▲ Positive7OTTROtter Tail CorpOtter Tail's 1,400 MW Pipeline Signals Data-Center DemandEarnings & guidance · Wiseek News● Neutral8AEVAAeva Technologies, Inc.Aeva Unveils Optical Product and Hyperscaler AI Deal, CFO ResignsProduct & regulatory · Wiseek News▲ PositivePro7TELATELA Bio, Inc.TELA Bio Q2 Revenue Seen Dipping 0.9% to $20M, Loss at $0.18; New CEO NamedEarnings & guidance · Wiseek News▼ Negative8MITKMITEK SYSTEMS INCMitek Raises Full-Year Guidance, Names New CRO to Drive GrowthEarnings & guidance · Wiseek News▲ PositivePro7BIAFbioAffinity Technologies, Inc.Q2 Revenue Up 19% but Loss Widens to $3.37M; Mexico Patent SecuredEarnings & guidance · Wiseek News▼ Negative
How Wiseek picks and scores these

How Wiseek curates this list

Every entry started life as licensed wire-service reporting (Reuters, Dow Jones Newswires, and similar publishers) covering ticker-attributable events. Wiseek's editorial pipeline ingests these in real time, runs each headline through our domain-tuned importance scorer, and surfaces only items rated 7 or higher on a 1–10 market-impact scale. Items below 7 are filtered out at the database query so the public feed stays signal-dense.

What "AI-ranked analysis" means

For each item we publish a plain-English summary, a sentiment label (positive / negative / neutral), and a structured list of key events extracted from the underlying source. Score, summary, and sentiment come from Wiseek's in-house models — not generic chatbot output. See our methodology for the full pipeline and our editorial policy for source-attribution standards.

What's not on this page

Generic market commentary, opinion columns, low-impact press releases, and items below the 7-point importance threshold. Wiseek aggregates and scores wire-service headlines; the underlying publishers retain their original reporting and are credited per article.

Track by company

Follow SEC filings and market news for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.